ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2016 American Transplant Congress

    Histone Deacetylase-2 Gene Deletion in Mice Mitigates Liver Ischemia/Reperfusion Injury.

    D. Murken,1 D. Aufhauser Jr,1 Z. Wang,2 G. Ge,2 W. Hancock,2,3 M. Levine.1,4

    1Department of Surgery, University of Pennsylvania, Philadelphia, PA; 2Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; 3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; 4Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, PA.

    Introduction: Ischemia/reperfusion injury (IRI) causes significant morbidity in liver transplantation and other surgical scenarios. A better understanding of the molecular mechanisms of IRI is required…
  • 2016 American Transplant Congress

    Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes Following Liver Transplantation: A Systematic Review.

    M. Konerman,1 D. Fritze,2 R. Weinberg,3 E. Spengler,1 C. Sonnenday,2 P. Sharma.1

    1Hepatology, Univ of Michigan, Ann Arbor, MI; 2Transplantation Surgery, Univ of Michigan, Ann Arbor, MI; 3Cardiology, Univ of Michigan, Ann Arbor, MI.

    Purpose: Cardiovascular (CV) events remain a major source of morbidity and mortality following liver transplantation (LT). This review evaluates the incidence of and risk assessment…
  • 2016 American Transplant Congress

    Outcomes of Liver Grafts from Donors with Very High Transaminases.

    P. Martins, A. Rawson, P. Mahboub, B. Movahedi, N. Dolgin, I. Bruggenwirth, A. Bozorgzadeh.

    Department of Surgery, Transplant Division, University of Massachusetts, Worcester, MA.

    Introduction: Traditionally, elevation of transaminases has been broadly used as markers of hepatic ischemic injury and crucial parameters for liver graft assessment. We wanted to…
  • 2016 American Transplant Congress

    How Small Is Too Small: A Comparison of Access and Survival by Weight in Pediatric Liver Transplant Recipients.

    E. Steen, R. Cotton, A. Rana.

    Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX.

    Introduction: Orthotopic liver transplantation is a well-established treatment modality for a wide variety of pediatric illness. With its associated technical challenges, paucity of size-matched allografts,…
  • 2016 American Transplant Congress

    Limited Hepatitis B Immune Globulin Following Liver Transplant for Hepatitis B.

    T. Sievers, J. Thompson, J. Lake.

    Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN.

    IntroductionThe hypothesis of this study was that the long-term outcomes in liver transplant (LTx) patients with hepatitis B virus (HBV) who were treated with nucleos(t)ide…
  • 2016 American Transplant Congress

    Improving the Efficiency, Safety and Cost of Evaluating Living Donor Liver Candidates Using Single Sequence MRI.

    M. Schilsky,1,2 K. Cartiera,1 S. Boga,1 S. Schilsky,3 S. Emre,1 D. Mulligan,1 J. Weinreb,1 G. Israel.1

    1Yale New Haven Transplantation Center, Transplantation and Immunology, Surgery, Yale University, New Haven, CT; 2Section of Digestive Diseases, Medicine, Yale University, New Haven, CT; 3Food and Drug Administration, Silver Springs, MD.

    Background: Current evaluation of donor candidates for adult-to-adult living donor liver transplant (LDLT) includes MRI and CT without and with contrast for defining liver anatomy.…
  • 2016 American Transplant Congress

    What Are the Charges and Costs of Transplanting High MELD Patients?

    K. Bortecen, B. Gelb, A. Winnick, G. Morgan, L. Teperman.

    Transplant Surgery, NYU Langone Medical Center, New York, NY.

    Purpose: There is a significant variation in the MELD scores and subsequent morbidity among liver recipients in the US. Larger OPOs consistently serve patients with…
  • 2016 American Transplant Congress

    DNA Methylation Patterns and Association with Graft Injury Severity Post Liver Transplantation.

    R. Gehrau, S. Bontha, V. Mas, D. Maluf.

    UVA, Charlottesville.

    Background: Epigenetics modifications in the graft may influence injury severity and function post liver transplantation (LT). This study aimed to interrogate the effect of different…
  • 2016 American Transplant Congress

    Intraoperative Blood Loss Is a Promoter of Early Tumor Recurrence in Liver Transplant Patients with High Risk Hepatocellular Carcinoma.

    A. Kornberg,1 U. Witt,1 J. Kornberg,2 H. Friess,1 K. Müller,3 K. Thrum.4

    1Surgery, Technical University, Munich, Germany; 2Anesthesiology, Ludwig-Maximilians-University, Munich, Germany; 3FSU, Jena, Germany; 4Pathology, Helios-Klinikum, Berlin, Germany.

    Background:Currently, there is an increasing body of evidence that risk of early hepatocellular carcinoma (HCC) relapse following liver transplantation (LT) may be promoted by mechanisms…
  • 2016 American Transplant Congress

    Barriers to the Wider Utilization of Living Donor Liver Transplantation (LDLT).

    A. Yegiants, E. Przybyszewski, A. Fox, J. Emond, B. Samstein.

    Center for Liver Disease and Transplantation, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY.

    Purpose: LDLT reduces waitlist mortality, improves access to transplantation and has post-transplant outcomes that are equivalent to or better than deceased donor transplant. Despite these…
  • « Previous Page
  • 1
  • …
  • 147
  • 148
  • 149
  • 150
  • 151
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences